Seco A J, Salgueiro M E, Manso G
Departamento de Medicina, Farmacologia, Facultad de Medicina, Oviedo, Spain.
Lung. 1995;173(5):321-8. doi: 10.1007/BF00176895.
The effect of beta 2-adrenoceptor agonists on airway smooth muscle relaxation may be subject to desensitization. It could be modified by glucocorticosteroid treatment. An increase in the beta 2 agonist response by glucocorticosteroids in vitro has been described. We studied the effects of acute and chronic treatment with dexamethasone on the relaxation response of tracheal smooth muscle to beta 2 agonists, fenoterol and salbutamol. Fenoterol showed a greater force of relaxation than salbutamol, and both drugs induced desensitization. Acute treatment with dexamethasone reduced desensitization to both beta 2 agonists. Chronic treatment (120 micrograms/kg of dexamethasone for 7 days) reduced the desensitization to fenoterol alone. Dexamethasone (200 micrograms/kg for 7 days) increased relaxation to salbutamol and reduced desensitization to both drugs. The interaction between beta 2 agonists and glucocorticosteroids could be important in the clinical use of both drugs in the treatment of asthma.
β2肾上腺素能受体激动剂对气道平滑肌舒张的作用可能会发生脱敏。它可能会受到糖皮质激素治疗的影响。已有研究描述了糖皮质激素在体外可增强β2激动剂的反应。我们研究了地塞米松急性和慢性治疗对气管平滑肌对β2激动剂(非诺特罗和沙丁胺醇)舒张反应的影响。非诺特罗的舒张力比沙丁胺醇更大,且两种药物均会引起脱敏。地塞米松急性治疗可降低对两种β2激动剂的脱敏作用。慢性治疗(120微克/千克地塞米松,持续7天)仅降低了对非诺特罗的脱敏作用。地塞米松(200微克/千克,持续7天)可增强对沙丁胺醇的舒张作用,并降低对两种药物的脱敏作用。β2激动剂与糖皮质激素之间的相互作用在这两种药物治疗哮喘的临床应用中可能具有重要意义。